<DOC>
	<DOCNO>NCT00933920</DOCNO>
	<brief_summary>The purpose study determine effect light meal pharmacokinetics pharmacodynamics aliskiren patient mild moderate hypertension .</brief_summary>
	<brief_title>Effect Light Meal Pharmacokinetic Pharmacodynamics Aliskiren Patients With Mild Moderate Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<criteria>Male female outpatient , 18 65 year age mild moderate hypertension Patients eligible able participate study Exclusion criterion : Severe hypertension Secondary form hypertension . Type 1 type 2 diabetes mellitus Serum potassium side laboratory reference range Any history hypertensive encephalopathy cerebrovascular accident Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2010</verification_date>
	<keyword>Aliskiren ,</keyword>
	<keyword>hypertension ,</keyword>
	<keyword>renin-angiotensin-aldosterone system ,</keyword>
	<keyword>pharmacokinetics ,</keyword>
	<keyword>pharmacodynamics</keyword>
</DOC>